Elevance Health (ELV) Operating Expenses (2009 - 2026)

Elevance Health (ELV) has 18 years of Operating Expenses data on file, last reported at $48.5 billion in Q2 2026.

• On a quarterly basis, Operating Expenses rose 2.22% year-over-year to $48.5 billion in Q2 2026; TTM through Jun 2026 was $195.3 billion, a 7.19% increase from a year earlier, with the FY2025 full-year figure at $192.4 billion, up 13.78% from the prior year.
• Operating Expenses for Q2 2026 stood at $48.5 billion, up from $47.9 billion in the prior quarter.
• Over the last five years, Operating Expenses for ELV reached as high as $49.5 billion in Q4 2025 and fell as low as $35.8 billion in Q1 2022.
• Historically, Operating Expenses has averaged $42.8 billion across 5 years, with a median of $41.4 billion in 2023.
• Across the five-year window, Operating Expenses rose 18.47% in 2022 and decreased 0.8% in 2024, its largest moves.
• Year by year, Operating Expenses stood at $38.9 billion in 2022, then rose by 7.1% to $41.6 billion in 2023, then climbed by 7.66% to $44.8 billion in 2024, then advanced by 10.47% to $49.5 billion in 2025, then declined by 2.01% to $48.5 billion in 2026.
• Per Business Quant data, the three most recent Operating Expenses figures were $48.5 billion in Q2 2026, $47.9 billion in Q1 2026, and $49.5 billion in Q4 2025.